Insulin Lispro Aabc

Save $417/mo

2× cheaper

LYUMJEV ® is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LYUMJEV ® is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.

United States

$743

per month

India

$326

per month

You save

−56%

save $417/mo · 56% cheaper

99.9K US scripts/yr$41.7M potential annual savings$74.2M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$743per month

India price$326per month

You save$41756% less

Based on 30 units per month. US $24.77 vs India $10.86 per unit.

How many months / courses?

Total over 1 periodSave $417$743 → $326

The bigger picture

Insulin Lispro Aabc is filled about 99.9K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$74.2M

If sourced from India

$32.5M

Potential annual savings

$41.7M

−56%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.